Health Care & Life Sciences » Pharmaceuticals | Sinil Pharmaceutical Co. Ltd.

Sinil Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
44,311
48,160
44,703
50,212
50,942
Cost of Goods Sold (COGS) incl. D&A
21,007
24,082
21,378
26,617
26,304
Gross Income
23,304
24,078
23,325
23,595
24,638
SG&A Expense
13,730
11,814
12,820
12,247
15,377
EBIT
9,489
12,264
10,506
11,348
9,261
Unusual Expense
1,061
639
78
37
1,026
Non Operating Income/Expense
18
175
285
146
344
Interest Expense
159
162
179
163
182
Pretax Income
8,864
12,335
10,546
11,736
8,722
Income Tax
1,540
2,156
1,782
1,698
1,132
Consolidated Net Income
7,324
10,179
8,764
10,038
7,591
Net Income
7,324
10,179
8,764
10,038
7,591
Net Income After Extraordinaries
7,324
10,179
8,764
10,038
7,591
Net Income Available to Common
7,324
10,179
8,764
10,038
7,591
EPS (Basic)
976.00
1,356.00
1,168.00
1,338.00
1,011.00
Basic Shares Outstanding
8
8
8
8
8
EPS (Diluted)
975.85
1,356.31
1,167.69
1,337.56
1,011.40
Diluted Shares Outstanding
8
8
8
8
8
EBITDA
11,568
14,352
12,969
14,367
12,679
Other Operating Expense
85
-
-
-
-
Non-Operating Interest Income
576
697
581
443
326

About Sinil Pharmaceutical Co.

View Profile
Address
28 Boksanggol-gil
Chungju-si NC 27304
Korea, Republic Of
Employees -
Website http://www.sinilpharm.com
Updated 09/14/2018
Shinil Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products. It operates through following business divisions: Drug, Health Functional Food, Cosmetics, Real Estate, and Other Product. The company was founded by Sung-So Hong in November 1971 and is headquartered in Chungju-si, South Korea.